Morgan Stanley’s Blonder Tongue Laboratories Inc BDR Stock Holding History

Morgan Stanley’s Portfolio BDR Stock Details BDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3	Closed	–	–	8243
2022 Q1	$0	Buy	+3	New	+$2	﹤0.01%	8313
2015 Q1	–	Sell	-2,567	Closed	-$7K	–	6707
2014 Q4	$7K	Buy	+2,567	New	+$4.48K	﹤0.01%	6279

Morgan Stanley's BDR Position: Q2 2022 in Review

Morgan Stanley sold out of Blonder Tongue Laboratories Inc (BDR) in Q2 2022, closing a stake of 3 shares.

Morgan Stanley first reported a position in BDR in Q4 2014 and held it in 2 quarters. The position peaked at $7K in Q4 2014. 0 funds tracked by Wall St. Rank hold BDR as of Q2 2022.

Morgan Stanley reported no remaining Blonder Tongue Laboratories Inc position as of Q2 2022 after selling out during the quarter.
Morgan Stanley sold 3 Blonder Tongue Laboratories Inc shares in Q2 2022.
Morgan Stanley first reported a position in Blonder Tongue Laboratories Inc in Q4 2014 and held it in 2 quarters.
Morgan Stanley's Blonder Tongue Laboratories Inc position peaked at $7K in Q4 2014.
0 funds tracked by Wall St. Rank held Blonder Tongue Laboratories Inc as of Q2 2022.

Based on Morgan Stanley's 13F filing for Q2 2022, filed 15 Aug 2022.